Electrochemical biosensor demonstrates enhanced signal output for granzyme B detection, suggesting effective clinical utility.
Peptides have great potential in the design and fabrication of biosensors because of their high specificity, multifunctionality, and relatively low cost. In this paper, we report an electrochemical biosensor leveraging multifunctional peptides and silver nanoparticles for integrated target recognition, self-assembly, and signal output. As a proof of concept, we chose granzyme B (GrB) as a model target. Specifically, when the target is present, the recognition peptide is cleaved, and the assembly peptide then anchors, exposing a positively charged sequence that attracts silver nanoparticles, thereby generating an electrochemical signal. The biosensor exhibits favorable analytical performance, with a linear detection range of 1 to 10000 fM and a remarkably low limit of detection (LOD) of 0.42 fM. Moreover, the biosensor has been successfully applied to the analysis of clinical samples, confirming its potential for clinical detection and application.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: